The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict OraSure Technologies' revenues will expand 17.6% and EPS will remain in the red.
The average estimate for revenue is $22.4 million. On the bottom line, the average EPS estimate is -$0.09.
Last quarter, OraSure Technologies tallied revenue of $20.9 million. GAAP reported sales were 20% higher than the prior-year quarter's $17.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.07. GAAP EPS were -$0.07 for Q1 compared to -$0.06 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 65.6%, 90 basis points better than the prior-year quarter. Operating margin was -17.4%, 270 basis points worse than the prior-year quarter. Net margin was -15.5%, 60 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $97.2 million. The average EPS estimate is -$0.25.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 197 members out of 218 rating the stock outperform, and 21 members rating it underperform. Among 57 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 49 give OraSure Technologies a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on OraSure Technologies is outperform, with an average price target of $13.58.
The healthcare investing landscape is littered with also-rans and a few major winners. Is OraSure Technologies performing well enough for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Click here for instant access to this free report.
- Add OraSure Technologies to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.